<bill session="112" type="hr" number="279" updated="2019-11-15T21:21:16Z">
  <state datetime="2011-05-25">REFERRED</state>
  <status>
    <introduced datetime="2011-05-25"/>
  </status>
  <introduced datetime="2011-05-25"/>
  <titles>
    <title type="display">Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.</title>
    <title type="official" as="introduced">Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.</title>
  </titles>
  <sponsor bioguide_id="C001058"/>
  <cosponsors/>
  <actions>
    <action datetime="2011-05-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2011-05-25" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2011-06-03">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Health promotion and preventive care"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2011-06-22T15:47:05Z" status="Introduced in House">Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications.

Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.</summary>
</bill>
